Coffee may prevent blepharospasm

Article

People who drink coffee are less likely to develop primary late onset blepharospasm.

People who drink coffee are less likely to develop primary late onset blepharospasm (BSP), according to a report published online ahead of print by the Journal of Neurology, Neurosurgery and Psychiatry.

Giovanni Defazio from the University of Bari, Italy and co-workers, investigated the effects of coffee and smoking in 166 patients with primary late onset BSP, 228 hospital control patients with primary hemifacial spasm and 187 population control subjects.

Unadjusted logistic regression analysis demonstrated a significant inverse association of prior coffee drinking and smoking with case status for the control groups. After adjusting for age, sex, disease duration, referral centre, years of schooling and coffee drinking/cigarette smoking, the smoking estimate lacked significance, whereas the association with coffee intake and BSP did not. The strength of the inverse association between BSP and coffee intake, tended to increase with the average number of cups drunk per day and there was a significant correlation between age of BSP onset and the number of cups per day, whereas no correlation was discovered with the number of packs of cigarettes per day.

It was concluded that coffee drinking may be inversely associated with the development of primary BSP and that this association may depend, in part, on the amount of coffee consumed.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.